Suha%20Jhaveri_edited.jpg

Suha Jhaveri, MBA

Executive in Residence

Suha Jhaveri has over 25 years of experience in healthcare product development. Her career has spanned disciplines such as strategic consulting (BCG), M&A integration (Chiron, BCG), business development (Metabolex, Kalobios), Global Commercialisation (Genentech, Ultragenyx) and Strategic Business Operations/Crisis Management (OBMedical, Chiron).

 

Currently, Suha is Vice President, Head of Commercialization for VIR Biotechnology in San Francisco, where she leads the commercial product development team for infectious disease assets, most notably a COVID-19 treatment launching this year. Previously she was Global Commercial Leader, New Product Planning for Ultragenyx Pharmaceuticals, and prior to that Chief Operating Officer for OBMedical Company. Previously she held several management positions with Genentech, Chiron Corporation/Novartis, and other life science therapeutic and medical device companies. Suha has worked extensively at seed-stage, mid-stage, and large companies, using insights from each to drive portfolio decision-making and optimization. Earlier in her career, she was a consultant with Boston Consulting Group.

 

Ms. Jhaveri received an MBA from Harvard University, a Masters of Science in Economic Development from the University of Sussex, and a Batchelor of Arts in Economics/International Relations with honors from Stanford.